Objective To analyze the effect of preoperative vaginal misoprostol on cervical softening. Methods A total of 58 patients undergoing induced abortion from January 2020 to January 2021 in our hospital were chosen as study subjects, and according to random number table, divided into a control group （29 cases, without preoperative cervical softening） and an observation group （29 cases, with preoperative cervical softening using vaginal misoprostol）. Comparisons were performed in intraoperative bleeding volume, operation time, cervical dilation diameter, dilation time, uterine contraction degree, anesthetic drug dosage, cervical dilation degree, pain scores before and after surgery, and side effects such as abortion syndromes. Results The intraoperative bleeding volume and the anesthetic drug dosage in the observation group were lower than those in the control group; the operation time and the dilation time were shorter; the cervical dilation diameter was larger; the uterine contraction degree was higher （P<0.05）. The effective cervical dilation rate in the observation group （100.00％） was higher than that in the control group （31.03％） （P<0.05）. Before surgery, the pain score in the observation group was higher than that in the control group （P>0.05）; whereas at postoperative 1 h, the pain score was lower （P<0.05）. Both groups completed the surgery successfully. The observation group had one case of abortion syndrome （3.45％, 1/29）, the control group had eight cases of abortion syndrome（27.59％, 8/29）, and all the cases of abortion syndrome improved after treatment. No serious adverse side effects and complications occurred, such as incomplete abortion and uterine perforation. The cose of abortion syndromes in the observation group was lower than that in the control group （P<0.05）. Conclusion Preoperative vaginal misoprostol application can reduce intraoperative bleeding volume, anesthetic drug dosage, pain degree after surgery, and abortion syndromes.
WANG Mengling
. Effect assessment of preoperative vaginal misoprostol on cervical softening[J]. Surgical Research and New Technique, 2021
, 10(4)
: 291
-294
.
DOI: 10.3969/j.issn.2095-378X.2021.04.013
[1] 沈海兰. 超导可视联合米索前列醇用于无痛高危人流90例疗效分析[J].实用妇科内分泌电子杂志,2019,6(32):71.
[2] Courtney K, Kelsey S, Colleen KS, et al.Prevalence,attitudes and knowledge of misoprostol for self-induction of abortion in women presenting for abortion at Midwestern reproductive health clinics[J]. Sex Reprod Health Matters,2019,27(1):118-125.
[3] 季小芳. 米索前列醇应用于孕早期无痛人流术前的临床观察[J].实用妇科内分泌电子杂志,2018,5(31):53-54.
[4] 程金彬. 无痛人流术中经阴道途径给予米索前列醇的临床观察[J].实用妇科内分泌电子杂志,2019,6(8):60-65.
[5] 叶丽洁. 米索前列醇在无痛人流术中的临床应用研究[J].实用妇科内分泌电子杂志,2016,3(5):46-48.
[6] 单咏梅. 间苯三酚联合米索前列醇对绝经后妇女行宫内节育器取出术术中宫颈可扩张程度及VAS评分的影响分析[J]. 现代医用影像学,2018,27(6):2188-2189.
[7] 唐海云. 米索前列醇片阴道给药用于无痛人流术效果观察[J].现代诊断与治疗,2016,27(5):871-872.
[8] 巫银玉. 米索前列醇应用于孕早期无痛人流术前的临床效果[J].临床合理用药杂志,2018,11(21):28-29.
[9] 沈文秀. 对接受无痛人流术的女性在术前应用不同剂量的米索前列醇扩张其宫颈的效果对比[J].当代医药论丛,2018,16(21):110-111.
[10] 阿依努尔. 米索前列醇在无痛人流术患者中的应用效果研究[J].新疆医学,2020,50(4):355-360.
[11] 罗来娥. 米索前列醇经阴道用药在妊娠早期无痛人流患者中的效果及价值评价[J].中国社区医师,2019,35(7):56-57.
[12] 杨秀珍,汪颖.探讨米索前列醇不同用法配合枸橼酸芬太尼、丙泊酚进行无痛人流麻醉的方案选择[J].卫生职业教育,2018,36(10):143-144.
[13] Sweed M, El‐Said M, Abou‐Gamrah A, et al. Comparison between 200,400 and 600 microgram rectal misoprostol before cesarian section:A randomized clinical trial[J]. J Obstet Gynaecol Res, 2019,45(3):585-591.
[14] 龚志宁. 米索前列醇阴道片与人流清宫术对自发性不全流产的治疗效果[J].中国实用医药,2016,11(21):218-219.
